EXS74539

REC-4539 · Exscientia AI Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for EXS74539, covering 2026-04-08 to 2026-04-08. Get the full timeline:

Most recent: Clinical Trial Update: Dose Determining Study of EXS74539 (REC-4539) in Participants With Select Solid Tumors [Phase 1]